CHO-NECTIN4 Cells
CAD$2,622.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entities the price is approximately €6,250. If you represent a commercial entity or are unsure which category applies, please contact us. CHO-NECTIN4 cells are a stable recombinant Chinese hamster ovary (CHO) cell line engineered to express human Nectin-4 (also known as PVRL4 or Poliovirus receptor-related protein 4), a type I transmembrane protein belonging to the nectin family of cell adhesion molecules. Nectin-4 is a well-established tumor-associated antigen that is overexpressed in multiple solid tumor types, including urothelial bladder carcinoma, breast cancer, non-small cell lung cancer, and pancreatic cancer, making it a clinically validated target for antibody-drug conjugates (ADCs) and other targeted immunotherapeutics. The ADC enfortumab vedotin, which targets Nectin-4, is approved for treatment of urothelial carcinoma, underscoring the therapeutic relevance of this antigen. CHO-NECTIN4 cells are widely used for the development and characterization of Nectin-4-directed antibodies, ADCs, bispecific antibodies, and CAR-T cell therapies. The stable recombinant expression system supports quantitative binding assays, ADCC/CDC cytotoxicity evaluations, receptor internalization studies, and high-throughput antibody screening by flow cytometry. The CHO background provides low endogenous expression of most human surface antigens, ensuring that observed signals are attributable to the stably expressed Nectin-4 transgene. This cell line is validated for use in drug discovery workflows, preclinical candidate selection, and mechanistic studies of Nectin-4 receptor biology. |
|---|---|
| Organism | Chinese hamster |
| Tissue | Ovary |
| Disease | Chinese hamster ovary, non-neoplastic; genetically engineered for NECTIN4 (PVRL4) surface expression |
| Applications | Antibody screening; ADC development; NECTIN4-targeted therapy development; urothelial/breast cancer research; flow cytometry |
Characteristics
| Age | Adult |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Cell type | Epithelial cells |
| Growth properties | Adherent/suspension |
Regulatory Data
| Citation | CHO-NECTIN4 (Cytion catalog number 305984) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10029 |
| CellosaurusAccession | CVCL_A8W9 |
| GMO Status | GMO-S1: This CHO cell line contains a NECTIN4 expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Surface antigens | NECTIN4 (PVRL4/CD112R) |
|---|
Handling
| Culture Medium | For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039) |
|---|---|
| Supplements | For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL. |
| Dissociation Reagent | For adherent cultures: Trypsin-EDTA |
| Doubling time | approx. 14-16 hours |
| Subculturing | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Split ratio | 1 to 5 |
| Seeding density | 2 to 5 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|